⌘K
Loading ticker…
Orchestra BioMed Holdings, Inc. Ordinary Shares · Healthcare · Medical Equipment
As of 2026-06-26, Orchestra BioMed Holdings, Inc. Ordinary Shares (OBIO) has a 3-month relative strength percentile of 31 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 55. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.1%, relative volume 23.72×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
31 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
OBIO is in a stage 3 topping pattern, week 5. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 5.3% / 6.0%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
OBIO is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $7M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $7M |
| VXFVanguard Extended Market ETF | 0.00% | $2M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | OBIO Jan avg: -7.93% median: -19.18% win: 25% σ: 26.20% n: 4 2023-01-30 → 2026-05-29 | OBIO Feb avg: 3.36% median: -0.78% win: 50% σ: 16.86% n: 4 2023-01-30 → 2026-05-29 | OBIO Mar avg: 19.86% median: -5.85% win: 25% σ: 59.96% n: 4 2023-01-30 → 2026-05-29 | OBIO Apr avg: -17.69% median: -17.03% win: 0% σ: 10.04% n: 4 2023-01-30 → 2026-05-29 | OBIO May avg: 11.07% median: -3.02% win: 25% σ: 30.78% n: 4 2023-01-30 → 2026-05-29 | OBIO Jun avg: -13.90% median: -5.96% win: 33% σ: 36.13% n: 3 2023-01-30 → 2026-05-29 (current) | OBIO Jul avg: -3.80% median: -9.45% win: 33% σ: 15.93% n: 3 2023-01-30 → 2026-05-29 | OBIO Aug avg: -4.57% median: -9.21% win: 33% σ: 9.45% n: 3 2023-01-30 → 2026-05-29 | OBIO Sep avg: 2.43% median: -9.16% win: 33% σ: 33.07% n: 3 2023-01-30 → 2026-05-29 | OBIO Oct avg: 3.75% median: 0.19% win: 67% σ: 51.83% n: 3 2023-01-30 → 2026-05-29 | OBIO Nov avg: 26.12% median: 32.62% win: 100% σ: 14.67% n: 3 2023-01-30 → 2026-05-29 | OBIO Dec avg: -1.39% median: -21.99% win: 33% σ: 41.86% n: 3 2023-01-30 → 2026-05-29 |